Increased stroke risk and lipoprotein(a) in a multiethnic community: The northern manhattan stroke study

Cerebrovascular Diseases

Volumn 30, Issue 3, 2010, Pages 237-243

  Boden Albala, Bernadette ^a,d   Kargman, Douglas E ^a   Lin, I Feng ^a   Paik, Myunghee C ^a   Sacco, Ralph L ^b   Berglund, Lars ^c  

^a Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NEUROLOGICAL INSTITUTE   (United States)

Author keywords

Ischemic stroke; Lipoprotein(a); Northern Manhattan Stroke Study

Indexed keywords

HIGH DENSITY LIPOPROTEIN; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

AGED; ARTICLE; ATHEROSCLEROSIS; BRAIN ISCHEMIA; CIGARETTE SMOKING; CORONARY ARTERY DISEASE; DIABETES MELLITUS; ETHNIC DIFFERENCE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RACE DIFFERENCE; RISK FACTOR; SOCIOECONOMICS;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HISPANIC AMERICANS; HUMANS; LIPOPROTEIN(A); LOGISTIC MODELS; MALE; MIDDLE AGED; RISK FACTORS; SOCIAL CLASS; STROKE;

EID: 77954884216     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000319065     Document Type: Article

References (36)

1. Smith G, Shipley M, Marmot M, Rose G: Plasma cholesterol concentration and mortality. JAMA 1992; 267: 70-76.
2. Sharrett A, Ballantyne C, Coady S, et al: Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein( a), apoliproproteins A-I and B, and HDL density subfractions: the Atherosclerosis Risk in Communities (ARIC) Study. Circulation 2001; 104: 1108-1113.
3. Iso H, Jacobs D, Wentworth D, Neaton J, Cohen J: Serum cholesterol levels and six-year mortality from stroke in 350,977 men screened from the Multiple Risk Factor Intervention Trial. N Engl J Med 1989; 320: 904-910.
4. Sacco R, Benson R, Kargman D, et al: Highdensity lipoprotein cholesterol and ischemic stroke in the elderly. JAMA 2001; 285: 2729-2735.
5. Schreiner P, Heiss G, Tyroler H, Morrisett J, Davis C, Smith R: Race and gender differences in the association of Lp(a) with carotid artery wall thickness: the Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb Vasc Biol 1996; 16: 471-478.
6. Alfthan G, Pekkanen J, Jauhiainen M, et al: Relation of serum homocysteine and lipoprotein( a) concentrations to atherosclerotic disease in a prospective Finnish population based study. Atherosclerosis 1994; 106: 9-19.
7. Bostom A, Gagnon D, Cupples L, et al: A prospective investigation of elevated lipoprotein( a) detected by electrophoreses and cardiovascular disease in women. The Framingham Heart Study. Circulation 1994; 90: 1688-1695.
8. Pantoni L, Sarti C, Pracucci G, Di Carlo A, Vanni P, Inzitari D: Lipoprotein(a) serum levels and vascular diseases in an older Caucasian population cohort. Italian Longitudinal Study on Aging (ILSA). J Am Geriatr Soc 2001; 49: 117-125.
9. Bernick C, Kuller L, Dulberg C, et al: Silent MRI infarcts and the risk of future stroke: the Cardiovascular Health Study. Neurology 2001; 57: 1222-1229.
10. Ariyo A, Thach C, Tracy R: Lp(a) lipoprotein, vascular disease, and mortality in the elderly. N Engl J Med 2003; 349: 2108-2115.
11. Smolders B, Lemmens R, Thijs V: Lipoprotein( a) and stroke. Stroke 2007; 38: 1959- 1966.
12. Morrisett J: The role of lipoprotein in atherosclerosis. Curr Atheroscler 2000; 2: 243-250.
13. Marcovina S, Albers J, Wijsman E, Zhang Z, Chapman N, Kennedy H: Differences in Lp(a) concentrations and apo[a] polymorphs between black and white Americans. J Lipid Res 1996; 37: 2569-2585.
14. Guyton J, Dahlen G, Patsch W, Kautz J, Gotto AJ: Relationship of plasma lipoprotein Lp9A0 levels to race and to apoliprotein B. J Lipid Res 1985; 37: 2569-2585.
15. Ridker P, Stampher M, Hennekens C: Plasma concentration of lipoprotein(a) and risk of future stroke. JAMA 1995; 273: 1269-1273.
16. Nagayama M, Shinohara Y, Nagayama T: Lipoprotein(a) and ischemic cerebrovascular disease in young adults. Stroke 1994; 25: 74-79.
17. Shintani S, Shiigai T, Arinami T: Silent lacunar infarction on magnetic resonance imaging (MRI): risk factors. J Neurol Sci 1998; 160: 82-86.
18. Nowak-Gottl U, Debus O, Findeisen EA: Lipoprotein(a): its role in childhood thromboembolism. Pediatrics 1997; 99:E11.
19. Misirli H, Somay G, Ozbal N, Yasar EN: Relation of lipid and lipoprotein(a) to ischemic stroke. J Clin Neurosci 2002; 9: 127-132.
20. Cerrato P, Imperoiale D, Fornego P, et al: Higher lipoprotein(a) levels in atherothrombotic than lacunar ischemic cerebrovascular disease. Neurology 2002; 58: 653-655.
21. Ohira T, Schreiner P, Morrisett J, Chambless L, Rosamond W, Folsom A: Lipoprotein(a) and incident ischemic stroke: the Atherosclerotic Risk in Communities (ARIC) study. Stroke 2006; 37: 1407-1412.
22. Nguyen T, Elleson R, Hodge D, Bailey K, Kottke T, Abu-Lebdeh H: Predictive value of electrophoretically detected lipoprotein(a) for coronary heart disease and cerebrovascular disease in a community-based cohort of 9,936 men and women. Circulation 1997; 96: 1390-1397.
23. Sacco R, Boden-Albala B, Gan R, et al: Stroke incidence among white, black and Hispanic residents of an urban community: the Northern Manhattan Stroke Study. Am J Epidemiol 1998; 147: 259-268.
24. Sacco RL, Elkind M, Boden-Albala B, et al: The protective effect of moderate alcohol consumption on ischemic stroke. JAMA 1999; 281: 53-60.
25. Gan R, Sacco R, Gu Q, Kargman D, Roberts J, Boden-Albala B: Lacunes, lacunar syndromes, and the lacunar hypothesis: the Northern Manhattan Experience. Neurology 1997; 48: 1204-1211.
26. Friedewald W, Levy R, Frederickson D: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without the use of preparative ultracentifuge. Clin Chem 1972; 18: 499-502.
27. Gaubatz J, Heideman C, Gotto A, Morrisett J, Dahlen G: Human plasma lipoprotein[a]: structural properties. J Biol Chem 1983; 258: 4582-4589.
28. Peynet J, Beaudeux J, Woimant F, Flourie F, et al: Apoliprotein(a) size polymorphism in young adults with ischemic stroke. Atherosclerosis 1999; 150: 389-396.
29. Emerging Risk Factors Collaboration: Lipoprotein( a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality. JAMA 2009; 302: 412-423.
30. Milionis H, Liberopoulos E, Goudevenos J, Bairaktari E, Seferiadis K, Elisaf M: Risk factors for first-ever acute ischemic non-embolic stroke in elderly individuals. Int J Cardiol 2005; 99: 269-275.
31. Sun L, Li Z, Zhang H, et al: Pentanucleotide TTTTA repeat polymorphism of apoli poprotein( a) gene and plasma lipoprotein(a) are associated with ischemic and hemorrhagic stroke in Chinese: a multicenter case-control study in China. Stroke 2003; 34: 1617-1622.
32. Petersen NH, Schmied AB, Zeller JA, Plendl H, Deuschl G, Zunker P: Lp(a) lipoprotein and plasminogen activity in patients with different etiology of ischemic stroke. Cerebrovasc Dis 2007; 23: 188-193
33. Dahl T, Kontny F, Slagsvold CE, Christophersen B, Abildgaard U, Ödegaard OR, Mørkrid L, Dale J: Lipoprotein(a), other lipoproteins and hemostatic profiles in patients with ischemic stroke: the relation to cardiogenic embolism. Cerebrovasc Dis 2000; 10: 110-117.
34. Byrne DJ, Jagroop IA, Montgomery HE, Thomas M, Mikhailidis DP, Milton N, Winder AF: Lipoprotein(a) does not participate in the early acute phase response to training or extreme physical activity and is unlikely to enhance any associated immediate cardiovascular risk. Clin Pathol 2002; 55: 280-285.
35. Kronenberg F, Trenkwalder E, Dieplinger H, Utermann G: Lipoprotein(a) in stroke plasma samples and the ravages of time: why epidemiological studies might fail? Arterioscler Thromb Vasc Biol 1996; 16: 1568-1572.
36. Angles-Cano E, de la Pena Diaz A, Loyau S: Inhibition of fibrinolysis by lipoprotein(a). Ann NY Acad Sci 2001; 936: 261-275.